Emmvee Q1 FY27: Margin Expansion Continues; 9.9 GW Order Book, Expansion On Track
Emmvee Photovoltaic Power, a pure-play Indian solar module and cell manufacturer, posted Q1 FY27 revenue of ₹1,555.5 crore, up 51% year-on-year. EBITDA rose 56% to ₹548.1 crore, with margins widening to 35%, while net profit more than doubled to ₹380.3 crore and net margin touched a new high of 24%. The numbers show how the company’s self-manufactured cell capacity is lifting profitability, even as a 9.9 GW order book and the June 2026 ALMM II mandate for domestic cells provide strong revenue visibility through FY27 and beyond.
| INR crore (consolidated) | Q1 FY26 | Q4 FY26 | Q1 FY27 | YoY % | QoQ % |
|---|---|---|---|---|---|
| Revenue from operations | 1,027.8 | 1,738.8 | 1,555.5 | +51% | -11% |
| EBITDA | 350.5 | 571.1 | 548.1 | +56% | -4% |
| EBITDA margin (%) | 34% | 33% | 35% | ||
| Net profit (PAT) | 187.7 | 392.4 | 380.3 | +103% | -3% |
| PAT margin (%) | 18% | 23% | 24% |
(Source: [announcement])
Margins reach a new band. For the full year FY26, EBITDA margin was 34% and net margin 21%. The improvement is driven by operating leverage and a jump in internal cell consumption. Cell utilisation hit 83% in Q1 FY27 (up from 79% in Q4 FY26), and module output reached a record 970 MW [announcement]. Because making your own cells is cheaper than buying them, the shift to captive sourcing has structurally raised margins over the past four quarters: the company’s EBITDA margin has held between 33% and 37% in each of those quarters .
Order book and the DCR tailwind. Emmvee booked 1.5 GW of new orders in the quarter, pushing its total order book to 9.9 GW—equivalent to over four quarters of work at current run-rates [announcement]. The order book is split among independent power producers (33%), commercial, industrial and government customers (39%), and others (28%) [announcement]. With ALMM II requiring domestic cells for grid-connected projects from June 2026, demand for DCR‑compliant modules is expected to broaden beyond government schemes to the C&I and rooftop segments. Management noted that “domestic cell supply remains tight, especially for TOPCon cells,” which supports pricing for integrated players like Emmvee [announcement]. In the May 2026 earnings call, CEO Suhas Manjunatha said new‑order margins were holding at levels similar to those in recent quarters .
Expansion on schedule. The 6 GW integrated module and cell facility (Unit‑7) is on track: module line by December 2026, cell line by March 2027, raising total installed capacity to 16.3 GW of modules and 8.9 GW of cells by early FY28 [announcement]. The project cost is ₹5,500 crore, with ₹3,300 crore of debt tied up at a sub‑8% rate; all equipment is ordered, and 60% of the hard‑cost orders are already placed [announcement]. A subsequent 9 GW wafer‑ingot plant is planned in two phases—5 GW in FY29, 4 GW in FY30—at an estimated capex of ₹5,000–5,500 crore, to be funded largely from internal accruals, pending clarity on the ALMM III wafer mandate [announcement].
A cleaner balance sheet. Finance costs fell to ₹11.1 crore in Q1 FY27 from ₹53.1 crore a year earlier, after IPO proceeds were used to repay term loans [announcement]. The company ended FY26 with net cash (debt minus cash) of −₹65.4 crore and a debt‑to‑equity ratio of just 0.05x . That leaves ample headroom to fund the coming expansion.
---